Evidence map›Paper›PMID 26743094›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges.

Teri Roberts, Jennifer Cohn, Kimberly Bonner, Sally Hargreaves

Registry-linked trialAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03553693 (Optimizing HIV Viral Load Monitoring and Outcomes for High Risk Populations), which is not on this map. Cited by 166 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
166citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03553693 nacompletednot on this mapstarted 2018, after this paper: background citation

Optimizing HIV Viral Load Monitoring and Outcomes for High Risk Populations

TypeinterventionalSponsorUniversity of California, San FranciscoRan2018 to 2020Enrolled2,443ConditionsHIVArmsRAPID-VL study intervention
3 · Its place in the literature

Who cites it

166 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Dried Blood Spots to Assess Cardiovascular-Kidney-Metabolic Health.Journal of the American Heart Association · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Antiretroviral Therapy for the Prevention of HIV-1 Transmission.The New England journal of medicine · 2016
    Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

106 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Teri RobertsMédecins Sans Frontières, Geneva, Switzerland.
Jennifer CohnMédecins Sans Frontières, Geneva, Switzerland.
Kimberly BonnerMédecins Sans Frontières, Geneva, Switzerland.
Sally HargreavesInternational Health Unit, Department of Medicine, Section of Infectious Diseases and Immunity, Imperial College London, United Kingdom.

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
NIAID NIH HHS P30 AI045008
6 · The paper itself

Abstract

Despite immense progress in antiretroviral therapy (ART) scale-up, many people still lack access to basic standards of care, with our ability to meet the Joint United Nations Programme on HIV/AIDS 90-90-90 treatment targets for HIV/AIDS dependent on dramatic improvements in diagnostics. The World Health Organization recommends routine monitoring of ART effectiveness using viral load (VL) testing at 6 months and every 12 months, to monitor treatment adherence and minimize failure, and will publish its VL toolkit later this year. However, the cost and complexity of VL is preventing scale-up beyond developed countries and there is a lack of awareness among clinicians as to the long-term patient benefits and its role in prolonging the longevity of treatment programs. With developments in this diagnostic field rapidly evolving-including the recent improvements for accurately using dried blood spots and the imminent appearance to the market of point-of-care technologies offering decentralized diagnosis-we describe current barriers to VL testing in resource-limited settings. Effective scale-up can be achieved through health system and laboratory system strengthening and test price reductions, as well as tackling multiple programmatic and funding challenges.

Indexed as

Antiretroviral Therapy, Highly ActiveHealth Plan ImplementationHealth ResourcesViral LoadAnti-HIV AgentsCD4 Lymphocyte CountDrug MonitoringHIV InfectionsHumansIndiaPoint-of-Care SystemsWorld Health OrganizationAnti-HIV Agentsantiretroviral therapymonitoringresource-limited settingsviral loadvirological

Identifiers

PMID26743094
PMCPMC4803106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.